Copeland JG, Arabia FA, Tsau PH, Nolan
PE, McClellan D, Smith RG, Slepian MJ. Total artificial hearts
Bridge to transplantation. Cardiol Clin 2003;21:105-117.
Barragan P, Bouvier J, Roquebert P, Macaluso G, Commeau P,
Comet B, Lafont A, Camoin L, Walter U, Eigenthaler M. Resistance
to Thienopyridines: Clinical Detection of Coronary Stent Thrombosis
by Monitoring of Vasodilator-Stimulated Phosphoprotein Phosphorylation.
Catheter Cardiovasc Interv 2003;59:295-302.
Gurbel PA, Bliden KP, Hiatt BL, O’Connor CM. Clopidogrel
for coronary stenting: response variability, drug resistance,
and the effect of pretreatment platelet reactivity Circulation
2003; 107:2908-2913.
Gurbel PA, Bliden KP. Interpretation of platelet inhibition
by clopidogrel and the effect of non-responders among patients
with stable angina pectoris scheduled for elective coronary
stent placement. Thromb Haemos 2000; 89: 783-7.
Gurbel PA, Cummings CC, Bell CR, Alford AB, Meister AF, Serebruany
VL. Onset and extent of platelet inhibition by clopidogrel
loading in patients undergoing elective coronary stenting:
the Plavix reduction of new thrombus occurrence (PRONTO) trial.
Am Heart J 2003; 145:239-247.
Järemo P, Lindahl TL, Fransson SG, Richter A. Individual
variations of platelet inhibition after loading doses of clopidogrel.
J Intern Med 2002; 252:233-238.
Lau WC, Waskell LA, Watkins PB, Neer CJ, Horowitz K, Hopp
AS, Tait AR, Carville DG, Guyer KE, Bates ER. Atorvastatin
reduces the ability of clopidogrel to inhibit platelet aggregation:
a new drug–drug interaction. Circulation 2003: 107:32-37.
Mobley JE, Bresee SJ, Wortham DC, Craft RM, Snider CC, Carroll
RC. Frequency of Non- Response Antiplatelet Activity of Clopidogrel
during Pretreatment for Cardiac Catheterization. Am J Cardiol
2004; 93(4):456-8.
Neubauer H, Günesdogan B, Hanefeld C, Spiecker M, Mügge
A. Lipophilic statins interfere with the inhibitory effects
of clopidogrel on platelet function – a flow cytometry
study. Eur Heart J 2003; Vol.24: 19:1744-1749.
10Serebruany VL, Steinhubl SR, Hennekens CH. Are antiplatelet
effects of clopidogrel inhibited by atorvastatin? A research
question formulated but not adequately tested. Circulation
2003; 107: 1568-1569.
Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A
Prospective, Blinded Determination of the Natural History
of Aspirin Resistance Among Stable Patients With Cardiovascular
Disease. J Am Coll Cardiol 2003; 14:6:961-965.
Zimmerman N, Wenk A, Kim U, Kienzle P, Weber A, Gams E, Schrör
K, Hohlfeld T. Functional and Biochemical Evaluation of Platelet
Aspirin Resistance After Coronary Artery Bypass Surgery. Circulation
2003; 108:542-547.
Craft RM, Chavez JJ, Bresee SJ, Wortham DC, Cohen E, Caroll
RC. A novel modification of the Thrombelastograph® assay,
isolating platelet function, correlated with optical platelet
aggregation. J Lab Clin Med 2004; 143:301-309.
Craft RM, Chavez JJ, Snider CC, Muenchen RA, Carroll RC.
Comparison of a modified Thrombelastograph® and PlateletWorks®
whole blood assays to optical platelet aggregation for monitoring
reversal of clopidogrel inhibition in elective surgery patients.
J Lab Clin Med 2005; 145(6):309-15.
Carroll RC, Craft RM, Chavez JJ, Snider CC, Bresee SJ, Cohen
E. A Thrombelastograph® whole blood assay for clinical
monitoring of NSAID-insensitive transcellular platelet activation
by arachidonic acid. J Lab Clin Med 2005; 146(1):30-5.
Return to top
|
